Zhitong Finance App News, Recco Bio-B (02179.HK) issued an announcement. The new drug marketing application for the company's new adjuvant recombinant herpes zoster vaccine REC610 (REC610) has recently been officially accepted by the Drug Evaluation Center of the China Drug Administration. Acceptance number: CXSS2500145.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Recco Bio-B (02179.HK) issued an announcement. The new drug marketing application for the company's new adjuvant recombinant herpes zoster vaccine REC610 (REC610) has recently been officially accepted by the Drug Evaluation Center of the China Drug Administration. Acceptance number: CXSS2500145.